HISTORY OF PRESENT ILLNESS:  The patient is a 56-year-old man with a history of metastatic melanoma who presented for elective resection of an anterior abdominal wall mass.
He had a recurrence in [**2177-8-24**] and underwent a right frontal node dissection.
He then developed a right inguinal recurrence after two months, after receiving interferon therapy.
He received resection and radiation therapy.
He was enrolled in the ECOG 4697 study, receiving GNCSF and a peptide vaccine.
He underwent partial small bowel resection with complete resection of tumor in [**2179-9-24**].
He was started on the allovectin trial.
He was then taken off the allovectin trial, started on biochemotherapy.
He now presents for elective resection of an abdominal anterior wall mass.
HOSPITAL COURSE:  The patient was admitted to Green Surgery and underwent abdominal wall resection, component release of ventral herniorrhaphy, resection of small bowel mesenteric metastases, and small bowel resection with anastomosis.
He tolerated the procedure well, and was transferred to the floor.
He was started on Kefzol IV.
The patient was loaded with Decadron and then started on 4 mg p.o.
He was also started on fosphenytoin, and transferred to the Intensive Care Unit for further monitoring.
On postoperative day six, his antiseizure regimen was changed to Dilantin 200 mg p.o.
On postoperative day seven his Decadron was changed to p.o.
Heparin 5000 units subcutaneously b.i.d.
Protonix 40 mg p.o.
Phenytoin 200 mg p.o.
Decadron 4 mg p.o.
Percocet 5/325 mg one to two tablets p.o.
Colace 100 mg p.o.
Insulin sliding scale as per attached flow sheet.
